26 Therapeutics Inc.

Private

MontrealHealthcare & Life Scienceshttps://www.26therapeutics.com/

Last Round

Pre Seed

Mar 4, 2026

Company Overview

26 Therapeutics Inc. is a biotechnology company developing first-in-class topical small-molecule therapies for dry eye disease and meibomian gland disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydry eye diseasemeibomian gland dysfunctionMGDsmall-molecule therapyCYP26B1 inhibitordrug discoveryophthalmologyocular surface healthpreclinical biotechbiotech startupevaporative dry eyetopical therapeuticseye care innovationbiotech pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

26 Therapeutics Inc. Comparables

Compare 26 Therapeutics Inc. with similar companies based on industry and business-model similarity.

26 Therapeutics Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
OtusOphta Ltd.	79%
Novaliq	76%
Stuart Therapeutics, Inc.	76%

View all Comparables

26 Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Mar 4, 2026

View all Funding Rounds

26 Therapeutics Inc. Investors

Notable investors and investment history

26 Therapeutics Inc. investors
Investor	Rounds
adMare BioInnovations	Pre Seed

View all Investors

26 Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

26 Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 26 Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal

Employee Range2

Year Founded2026

Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.